MORPHIC THERAPEUTIC UK LTD

Active Basingstoke

Research and experimental development on biotechnology

3 employees website.com
Research and experimental development on biotechnology
M

MORPHIC THERAPEUTIC UK LTD

Research and experimental development on biotechnology

Founded 2 Mar 2022 Active Basingstoke, United Kingdom 3 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 25 Apr 2025 Next due 30 Sept 2026 4 months remaining
Confirmation Submitted 31 Mar 2025 Next due 15 Mar 2026 2 months overdue
Net assets £340K £619K 2024 year on year
Total assets £745K £517K 2024 year on year
Total Liabilities £405K £102K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Lilly House Basingview Basingstoke Hampshire RG21 4FA United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for MORPHIC THERAPEUTIC UK LTD (13949015), an active company based in Basingstoke, United Kingdom. Incorporated 2 Mar 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£215.72k

Decreased by £31.34k (-13%)

Net Assets

£339.82k

Decreased by £619.48k (-65%)

Total Liabilities

£404.89k

Increased by £102.12k (+34%)

Turnover

N/A

Employees

3

Decreased by 2 (-40%)

Debt Ratio

54%

Increased by 30 (+125%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Wright, Kristina MignonDirectorAmericanUnited Kingdom478 Aug 2025Active

Shareholders

Shareholders (1)

Morphic Therapeutic, Inc.
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active

Morphic Therapeutic, Inc.

Unknown

Active
Notified 2 Mar 2022
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Feb 2026GazetteGazette Notice Voluntary
11 Feb 2026DissolutionDissolution Application Strike Off Company
3 Sept 2025OfficersChange to director Kristina Mignon Wright on 1 Sept 2025
14 Aug 2025OfficersAppointment of Kristina Mignon Wright as director on 8 Aug 2025
14 Aug 2025OfficersTermination of Yuya Nonaka as director on 8 Aug 2025
24 Feb 2026 Gazette

Gazette Notice Voluntary

11 Feb 2026 Dissolution

Dissolution Application Strike Off Company

3 Sept 2025 Officers

Change to director Kristina Mignon Wright on 1 Sept 2025

14 Aug 2025 Officers

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

14 Aug 2025 Officers

Termination of Yuya Nonaka as director on 8 Aug 2025

Recent Activity

Latest Activity

Gazette Notice Voluntary

2 months ago on 24 Feb 2026

Dissolution Application Strike Off Company

2 months ago on 11 Feb 2026

Change to director Kristina Mignon Wright on 1 Sept 2025

8 months ago on 3 Sept 2025

Appointment of Kristina Mignon Wright as director on 8 Aug 2025

9 months ago on 14 Aug 2025

Termination of Yuya Nonaka as director on 8 Aug 2025

9 months ago on 14 Aug 2025